103 related articles for article (PubMed ID: 15968321)
1. [Effects of estrogen, progestin and mifepristone on endometrial carcinoma cell lines].
Lu Y; Yu L; Chen CL; Liao QP
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):284-6. PubMed ID: 15968321
[TBL] [Abstract][Full Text] [Related]
2. [Functional study of progesterone receptor isoforms in endometrial cancer cell lines].
Lu Y; Liao QP; Chen CL; Yu L
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):475-9. PubMed ID: 17068617
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines.
Navo MA; Smith JA; Gaikwad A; Burke T; Brown J; Ramondetta LM
Cancer Chemother Pharmacol; 2008 Aug; 62(3):483-9. PubMed ID: 18004570
[TBL] [Abstract][Full Text] [Related]
4. [Cell culture--its application in the study of hormone and endometrial carcinoma and feed-back to clinical medicine].
Kuramoto H
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Aug; 40(8):1050-5. PubMed ID: 3150847
[TBL] [Abstract][Full Text] [Related]
5. Early effects of high concentrations of progesterone and mifepristone A gene expression study of endometrial cancer cells (Ishikawa).
Ørbo A; Moe BT; Grønaas H; Paulssen RH
J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):139-49. PubMed ID: 19138738
[TBL] [Abstract][Full Text] [Related]
6. Effect of mifepristone on proliferation and apoptosis of Ishikawa endometrial adenocarcinoma cells.
Li A; Felix JC; Minoo P; Amezcua CA; Jain JK
Fertil Steril; 2005 Jul; 84(1):202-11. PubMed ID: 16009178
[TBL] [Abstract][Full Text] [Related]
7. [Overexpression of estrogen receptor-related receptor alpha can stimulate estrogen receptor negative endometrial cancer cell proliferation].
Sun PM; Wei LH; Gao M; Wang JL; Zhao LJ; Wang DP; Zhang JX
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):408-11. PubMed ID: 17697604
[TBL] [Abstract][Full Text] [Related]
8. Levonorgestrel, medroxyprogesterone and progesterone cause a concentration-dependent reduction in endometrial cancer (Ishikawa) cell density, and high concentrations of progesterone and mifepristone act in synergy.
Moe BT; Vereide AB; Orbo A; Jaeger R; Sager G
Anticancer Res; 2009 Apr; 29(4):1047-52. PubMed ID: 19414344
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa): progesterone-induced expression of the alpha1 integrin.
Lessey BA; Ilesanmi AO; Castelbaum AJ; Yuan L; Somkuti SG; Chwalisz K; Satyaswaroop PG
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):31-9. PubMed ID: 9009235
[TBL] [Abstract][Full Text] [Related]
10. [Effects of proteasome inhibitor MG132 on cell proliferation, apoptosis, and cell cycle in HEC-1B and Ishikawa cells].
Zhang Q; Huang J; Li DQ; He YD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):830-3, 838. PubMed ID: 23387207
[TBL] [Abstract][Full Text] [Related]
11. [Study on the modulation of estrogen receptor isoforms alpha in endometrial carcinoma cells using antisense oligodeoxyribonucleotides].
Zhang Y; Liao QP; Yu L; Chen CL; Zhao J
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 37(2):155-8. PubMed ID: 15841144
[TBL] [Abstract][Full Text] [Related]
12. Steroid hormones regulate the release of immunoreactive beta-endorphin from the Ishikawa human endometrial cell line.
Makrigiannakis A; Margioris A; Markogiannakis E; Stournaras C; Gravanis A
J Clin Endocrinol Metab; 1992 Aug; 75(2):584-9. PubMed ID: 1639959
[TBL] [Abstract][Full Text] [Related]
13. [Regulation of Bub1 mRNA expression in endometrial carcinoma Ishikawa cells by estrogen and paclitaxel].
Chen YH; Li XP; Wang Y; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):686-90. PubMed ID: 21092550
[TBL] [Abstract][Full Text] [Related]
14. [Cell cycle analysis of endometrial cancer cells in vitro treated with growth factor and steroid hormone].
Oyama S; Izutsu T
Hum Cell; 1992 Dec; 5(4):363-71. PubMed ID: 1304800
[TBL] [Abstract][Full Text] [Related]
15. The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism.
Hevir-Kene N; Rižner TL
Chem Biol Interact; 2015 Jun; 234():309-19. PubMed ID: 25437045
[TBL] [Abstract][Full Text] [Related]
16. Effects of mifepristone on vascular endothelial growth factor and thrombospondin-1 mRNA in Ishikawa cells: implication for the endometrial effects of mifepristone.
Mirkin S; Archer DF
Contraception; 2004 Oct; 70(4):327-33. PubMed ID: 15451338
[TBL] [Abstract][Full Text] [Related]
17. In vitro cytotoxicity of 4'-OH-tamoxifen and estradiol in human endometrial adenocarcinoma cells HEC-1A and HEC-1B.
Cuevas ME; Lindeman TE
Oncol Rep; 2015 Jan; 33(1):464-70. PubMed ID: 25351552
[TBL] [Abstract][Full Text] [Related]
18. The biological effects of macrophage-colony-stimulating factor induced by progestin on growth and differentiation of endometrial adenocarcinoma cells.
Kimura T; Azuma C; Saji F; Tokugawa Y; Takemura M; Miki M; Ono M; Tanizawa O
Int J Cancer; 1991 Sep; 49(2):229-33. PubMed ID: 1831804
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
Gong Y; Ballejo G; Murphy LC; Murphy LJ
Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100
[TBL] [Abstract][Full Text] [Related]
20. Estrogen activates migration potential of endometrial cancer cells through basement membrane.
Fujimoto J; Hori M; Ichigo S; Morishita S; Tamaya T
Tumour Biol; 1996; 17(1):48-57. PubMed ID: 7501972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
